X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - DRUGS.COM - Clinical Trials News - 28/Jun 05:07

Rocket Pharmaceuticals Provides Regulatory Update on Kresladi (marnetegragene autotemcel; marne-cel)

CRANBURY, N.J.--(BUSINESS WIRE)--Jun. 28, 2024-- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet needs, today...

Articles similaires

Sorry! Image not available at this time

FDA Rejects Rocket's (RCKT) Gene Therapy BLA for Rare Disease

zacks.com - 01/Jul 14:31

Per the FDA, Rocket (RCKT) needs to submit additional manufacturing information on Kresladi gene therapy to secure approval for severe leukocyte...

Sorry! Image not available at this time

Hepatitis B Virus Infection Pipeline 2024 | Vir Biotechnology, Arbutus Biopharma, Nucorion Pharmaceuticals, Xian Xintong Pharmaceutical Research, Dong-A ST Co. Ltd., Gilead Sciences

mountaintoday.in - 11/Jul 18:36

DelveInsight, “Hepatitis B Virus Infection Pipeline Insight 2024” report provides comprehensive insights about 80+ companies and 90+...

Sorry! Image not available at this time

Scientists Find Genetic Keys to Immune Disorders

medindia.net - 07/Jul 17:02

Researchers have discovered several rare types of helper T cells linked to immune disorders like multiple sclerosis, rheumatoid arthritis, and...

Sorry! Image not available at this time

Major Depressive Disorder Pipeline 2024 | GH Research, Praxis Precision Medicines, AbbVie, Gedeon Richter, Intra-Cellular Therapies, Bristol-Myers Squibb, Relmada Therapeutics, SAGE Therapeutics,

mountaintoday.in - 09/Jul 18:48

DelveInsight, “Major Depressive Disorder Pipeline Insight 2024” report provides comprehensive insights about 75+ companies and 75+...

Sorry! Image not available at this time

Expanded HyBryte Treatment Demonstrating Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma

drugs.com - 10/Jul 01:07

PRINCETON, N.J., July 9, 2024 /PRNewswire/ -- Soligenix, Inc., (Soligenix or the Company), a late-stage biopharmaceutical company focused on...

Sorry! Image not available at this time

Regeneron: Senior Manager, Regulatory Affairs IVD

pharmiweb.com - 02/Jul 00:00

Competitive: Regeneron: Regeneron is advancing its pipeline portfolio using a data-driven human translational approach. The In Vitro Diagnostic (IVD)...

Sorry! Image not available at this time

Hypertension Pipeline 2024 | Quantum Genomics, CinCor Pharma, Mineralys Therapeutics, Alnylam Therapeutics, Ionis Pharmaceuticals, Future Medicine, Pharmosa BioPharm, Aerovate Therapeutics, Novartis,

mountaintoday.in - 11/Jul 18:48

DelveInsight, “Hypertension Pipeline Insight 2024” report provides comprehensive insights about 100+ Hypertension companies and 100+...

Sorry! Image not available at this time

Pancreatic Cancer Pipeline 2024 | ERYtech Pharma, Jiangsu HengRui Medicine Co., Ltd., FibroGen, Novartis AG, AB Science, Eleison Pharmaceuticals, Cornerstone Pharmaceuticals, Panbela Therapeutics

mountaintoday.in - 08/Jul 18:52

DelveInsight’s, “Pancreatic Cancer Pipeline Insight 2024” report provides comprehensive insights about 290+ companies...

Sorry! Image not available at this time

Enveric Biosciences Announces Patent Granted for Drug Candidate

financialpost.com - 10/Jul 12:15

US patent includes broad claims for treating brain neurological disorders CAMBRIDGE, Mass. — Enveric Biosciences (NASDAQ: ENVB) (“Enveric”...

Sorry! Image not available at this time

Scientists Find Genetic Keys to Immune Disorders

medindia.net - 07/Jul 17:00

Scientists have uncovered new types of T cells and associated genetic enhancers linked to immune disorders such as multiple sclerosis and rheumatoid...

Les derniers communiqués